Genentech Inc. won regulatory approval Tuesday to market an eye implant that can be refilled every six months with an already ...

The following is a summary of “Evaluating lipid-lowering drug targets for full-course diabetic retinopathy,” published in the ...

A review of the cases, coupled with the latest research in the field, led the authors to hypothesize that rapid changes ... eye disease in people with Type 2 diabetes. “Because of the association of ...

As a retina specialist, one of the most important aspects of eye care I focus on is the prevention and treatment of diabetic retinopathy. This condition is a leading cause of blindness in adults, yet ...

Popular GLP-1 medications like semaglutide and tirzepatide have been linked to rare vision issues, including NAION, raising ...

Roche’s Susvimo, a refillable eye implant for diabetic macular edema, provides continuous delivery of ranibizumab, showing ...

EyePoint Pharmaceuticals Inc. (EYPT), which reported positive interim 16-week data from its phase II VERONA clinical trial last ...

The FDA has approved Susvimo (ranibizumab injection) for the treatment of patients with diabetic macular edema.